This talk was presented at the 29th Conference on Primary Care Access, Monterey, CA April 16, 2018
Many officials
and policymakers pay lip service to the importance of health, but most of the
actual support (spelled M-O-N-E-Y) is for treatments for individuals, often
with uncommon diseases. Being on the “frontiers of knowledge” is much sexier
than rather than the old, pedestrian “taking care of people”. And such policies
ensure enormous profit for drug manufacturers, who, like military contractors,
are guaranteed huge returns while
most Americans are not even guaranteed subsistence.
We abhor the
individual excesses of Martin Shkreli and Turing jacking up the price of pyrimethamine (Daraprim ®) from
$13.50 to $750 a pill (he has been sent to prison but not for this action
against the health of the people; rather he committed the much worse sin of
defrauding investors), or Heather Bresch and Mylan raising the price of Epi-Pen ® from $100
to $600, or the manufacturers of colchicine (URL Pharma), with the complicity
of the FDA, being allowed to patent a drug that was identified as effective for
gout in Egyptian papyri in 1500 BC and raise the price from a few cents to $5 a
pill. And what is there to say about the scammer Elizabeth Holmes and Theranos
and its A-List Board of Directors?
The Atlantic recently told us the history of
the creation and marketing of Oxy-Contin ® by the Sackler brothers. When they bought Purdue, they
inherited an expiring patent for extended-release morphine. So they not only
developed extended-release oxycodone and marketed it, taking advantage of the
public (and physicians’) caution about morphine, they greatly broadened the
indications for this drug, which is just as addictive, from cancer and
sickle-cell and the like to any chronic pain, especially back pain. Thus, we
almost all are eligible users, and we see the results with our nation’s opioid
crisis.
If we are still
practicing, we see the results of the “breakthroughs” in recombinant DNA “-ab” drugs
(actually, anyone who watches TV will see the ads for them), promising (occasionally
with some validity) new hope for sufferers from cancer, auto-immune disease,
and a variety of neurologic conditions. The TV ads do not contain, and I hope that
we as physicians are aware of, the prices, often $30,000 to $100,000 a year or
more, far more than the average family income in the US. The frequency of
serious side effects, including death, from these drugs is very real – many are
immune system stimulants that frequently, not rarely, cause autoimmune
hepatitis, pancreatitis and the like – and these are not clearly portrayed on
TV, or in marketing to physicians.
Even when the
individual is partially shielded from the cost by insurance, the out-of-pocket
costs to patients can still be enormous. In any case, no matter who is paying,
the pharmaceutical companies are making out like the bandits they are, and less
and less money within the whole system is actually available for population
health, for prevention, for public health, for treatment of common diseases
like hypertension and diabetes. And even for those conditions, we keep seeing
newer – and always more expensive – drugs. While all the new diabetes drugs
have some use for some individuals, many people with diabetes are still getting
inadequate basic treatment with metformin, insulin, and good counseling and
support for diet and exercise.
And what can be
said about “precision medicine” (sometimes called “personalized medicine”)?
Tens, or hundreds, of millions of dollars spent or promised by the federal
government, promoted by former President Obama as part of the “moonshot on
cancer”, the idea that
every individual will have a relatively unique treatment based upon learning
and understanding her genetic makeup. The promise is that we will be able to
prescribe treatments for cancer and other horrible diseases as precisely as we
target antibiotics to the culture results (and, I imagine, overprescribe them
as we do with antibiotics). Pursuit of the money being allocated for these
“cures”, as well as the cachet of being “scientific industry leaders”, has
become a major motivator of medical school deans and chancellors, with every
academic medical center developing Institutes for precision or personalized
medicine.
What, by the way,
has been the outcome? Not much, so far. Two genes have been shown to, themselves
alone, cause cancers, and they have been well-known for a long time, BRCA-1 and
BRCA-2. And the amazing precision/personalized medicine treatments? Well, get
mammography earlier and more often and maybe consider prophylactic bilateral
mastectomy. Where are the precision cocktails that cure each person? Do not
fret; billions more will be spent on looking for them for years to come.
Is there a problem with this? Taken in isolation, pursuing effective treatments for terrible diseases that affect a significant (if relatively small) proportion of our population is not intrinsically a bad thing. But nothing is done in isolation. Those dollars that NIH spends on looking for these treatments, those insurance company dollars spent paying for outrageously overpriced drugs, the infrastructure development in our academic medical center that continues to support high-tech, high-specialization research and care, are dollars not being used for population health, public health, prevention and primary care, not being used to actually, effectively and broadly implement the treatment strategies that we know work so that they are not only available to but used for the benefit of everyone.
This is what we,
as family doctors and primary care providers, and public health workers, can
do. It is important, cost effective, and will make a real difference in the
health of the population. But because it is cost-effective, it is not
profitable for those corporations that have great influence in public policy,
and so it continues to be recognized mostly with words and not resources.
Some years ago
the VCU Center for Human Needs developed the County Health Calculator. You can
click on any state, or any county, and find out the number of deaths per year, number of people with
diabetes, cost of diabetes, percent of people with greater than a high school
education, and percent of people with an income of at least twice the poverty
level. You can compare to the best and worst county or state, and a neat slider
lets you see how many lives and dollars would be saved if you had higher or
lower percents. Here is
Monterey County, CA, where we are. Despite the
impression that might be generated by Reese Witherspoon’s HBO show “Big Little
Lies”, it is not the richest or best-educated county in the state, but
closer to the middle. Allocating more of our money to addressing
core societal functions, like education and poverty, will make a big difference
in health, much more than any individually-directed medical care.
It should be
obvious that the emphasis in medicine and health care to focus on individual
treatments, despite (and maybe because of) huge costs (and remember, costs are
someone’s profits!), rather than on interventions to improve the health of our
overall population, is totally related to the political and social conditions
and circumstances I spoke about at the beginning. We not only feel we are
alone, we are actively being encouraged and directed to feel alone, and that we
just need to look out for ourselves, and the treatments for our diseases, and
our housing and food and children’s education and tax burden, and not for
anyone else.
This serves the
dual purpose of 1) pursuing, as I hope I have demonstrated for medical care
(and others have also demonstrated for military contracting and other areas),
strategies that maximize corporate profits, as well as 2) limiting the
probability that people will organize together to attack the core structure of
cynicism, exploitation, and greed that has become so ubiquitous that we can
often not imagine any other way of society being organized.
I have talked
about a number of issues, which I think are all related to our health, as
individuals and as a nation. I have talked about social isolation, consumerism,
a health system that is organized mainly for profit, the excesses of
pharmaceutical manufacturers, “precision” or “personalized” medicine, and
community health. Changing all of this is about changing society, but I think
we, as health professionals, definitely have something to contribute. Whenever
we think about these issues, whenever we are confronted by the false idea that
we are each alone, that we cannot band together, that we should not care for
the others in our society, that there is not value in social cohesion, we need
to resist it and increase our efforts to work with others. As physicians and
health workers, especially in public health and primary care, we need to
continue to demand that most health
dollars are spent on the strategies that benefit the health of most of the
people.
While policymakers and subspecialists
and deans talk about “personalized medicine”, we as family doctors and other
primary care providers, talk about personal
medicine. We are talking about the interactions between
people – the medical term for whom is “patients” -- who need to be heard, and
validated, and supported, with doctors and other providers who have enough time
to do so. This is where the magic of personal
medicine happens, not mainly in the provision of ever-more-expensive dangerous
drugs and procedures. It is what we know how to do, and need to continue to
teach others to do, and it is where we need to direct our efforts. It will not
be easy, given the poor pay and resultant shortages of primary care doctors,
and the mega-mergers that employ strategies such as retail clinics, currently
being adopted. These strategies combine two major themes I have mentioned – it is “corporate profit meets social
isolation and instant gratification”, where people are encouraged to no longer
value the relationships that come from continuity and community-based practices.
We may well be on
the road to 1984, even though it’s 34 years late. But I think we can still band together and resist going
all the way there.